1,476
Views
35
CrossRef citations to date
0
Altmetric
REVIEW

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience

ORCID Icon, , , ORCID Icon, , , & show all
Pages 135-148 | Received 17 Nov 2022, Accepted 12 Jan 2023, Published online: 19 Jan 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.